ArticlePLoS neglected tropical diseases2026
Molecular evidence of Echinococcus canadensis (G6/G7) predominance in Mongolian livestock and its implications for control.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCystic echinococcosis (CE), caused by Echinococcus granulosus sensu lato (E. granulosus s.l.), is a major zoonotic disease causing substantial health and economic losses, particularly in pastoral communities. WHO and WOAH recommend combining regular dog deworming with sheep vaccination (EG95) for control. However, genotype data are important for vaccination planning, as EG95 mainly targets G1/G3 in sheep and evidence of protection against other genotypes is limited. In Mongolia, molecular data from livestock, especially sheep, remain scarce despite the large sheep population. We therefore aimed to determine the genotype distribution of E. granulosus s.l. among livestock, particularly sheep, across Mongolia's endemic provinces.
methodsFrom August to December 2024, we conducted an abattoir-based cross-sectional survey in four provinces (Umnugobi, Bayankhongor, Dundgobi, and Tuv). Sheep, goats, and camels were examined for hydatid cysts. DNA was extracted, the COX1 gene was amplified by PCR and sequenced using the Sanger method, and published diagnostic COX1 sites were used to refine G6/G7 assignments; phylogenetic and haplotype analyses were performed with regional reference data.
resultsCysts were detected in 2.5% (115/4,578) of animals, and 0.31% (14/4,578) were molecularly confirmed as E. granulosus s.l. Among them, 93% (13/14; 10 sheep, 2 goats, 1 camel) were Echinococcus canadensis (G6/G7) and 7% (1/14; 1 sheep) were Echinococcus granulosus s.s. (G1/G3). Five COX1 haplotypes were identified: four E. canadensis haplotypes (H1-H4) and one E. granulosus s.s. haplotype (H5). Haplotypes H1-H3 were consistent with G6, whereas H4 was consistent with G7a. These haplotypes grouped with reference isolates from Mongolia and neighbouring countries, as well as from other endemic regions included in the network.
conclusionsThis study strengthens evidence that E. granulosus s.l. infections in Mongolian livestock are predominantly caused by Echinococcus canadensis G6/G7 and shows, for the first time, that this taxon predominated among successfully genotyped isolates from sheep in the surveyed areas. These findings support genotype-informed surveillance for vaccination planning, particularly in mixed-genotype settings, while underscoring the importance of dog deworming and safe offal disposal. Our findings further clarify CE transmission patterns in Mongolia and the wider region, highlight the transboundary nature of CE, and support the need for coordinated cross-border surveillance and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.